Methylprednisolone acetate injectable recalls

The FDA has published 17 recalls involving Methylprednisolone acetate injectable since 2020. The latest was reported on 31 May 2023. Most were for manufacturing (cgmp) deviations. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls17since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 31 May 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 16 94%Class III 1 6%

Why methylprednisolone acetate injectable is recalled

By year

All methylprednisolone acetate injectable recalls, newest first

17 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIMethylprednisolone Acetate Injectable Suspension recalledAmneal Pharmaceuticals of New YorkPackaging DefectsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension USP, 40 mg/mL recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIMethyLPREDNISolone Acetate Injectable Suspension, USP, 40 mg/mL recalledMckesson Medical-Surgical Inc. Corporate OfficeManufacturing (CGMP) DeviationsNationwide

Should you stop taking Methylprednisolone acetate injectable?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.